|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 37.00 | ACUITE BB | Reaffirmed | Issuer not co-operating* | - |
| Total Outstanding | 37.00 | - | - |
|
Rating Rationale |
|
Acuité has reaffirmed the long-term rating of ‘ACUITE BB’ (read as ACUITE double B) on the Rs.37.00 Crore bank facilities of KBK Biotech Private Limited. The rating continues to be flagged as “Issuer Not Cooperating” and is based on the best available information.
|
| About the Company |
|
Andhra Pradesh based KBK Biotech Private Limited was incorporated in 2015. It is engaged in manufacturing of Extra Neutral Alcohol (ENA), Impure Spirit (IS) and Distillers Dried/Wet Grains with soluble (DDGS), Hand Sanitizers and Captive Power Generation of 2MW. The commercial operations of the company were started from July 2019. The company is promoted by Mr. Balarama Krishna Kundula, Mr. Ganga Bhavani Kundula, Mr. Murali Krishna Kundula and Mr. Suresh Kumar Kundula . From March 2020, the company started manufacturing hand sanitizers.
|
| Unsupported Rating |
| None |
| Non-cooperation by the issuer/borrower: |
|
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date.
Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies. |
| Limitation regarding information availability: |
|
The rating is based on information available from sources other than the issuer / borrower (in the absence of information provided by the issuer / borrower). Acuité endeavored to gather information about the entity / industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based.
|
| Rating Sensitivity |
|
No information provided by the issuer / available for Acuite to comment upon.
|
| Liquidity Position |
|
No information provided by the issuer / available for Acuite to comment upon.
|
| Outlook |
|
Not Applicable
|
| Other Factors affecting Rating |
| None |
| Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
| Operating Income | Rs. Cr. | 172.33 | 152.91 |
| PAT | Rs. Cr. | 6.55 | 6.23 |
| PAT Margin | (%) | 3.80 | 4.08 |
| Total Debt/Tangible Net Worth | Times | 4.81 | 2.07 |
| PBDIT/Interest | Times | 4.31 | 3.22 |
| Status of non-cooperation with previous CRA |
|
Not Applicable
|
| Any other information |
|
None
|
| Applicable Criteria |
|
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
| Note on Complexity Levels of the Rated Instrument |
|
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in.
|
|
| |
|
|
||||||||||||||||||||||||||||||||||||
|
| |
|
Contacts |
|
|
|
About Acuité Ratings & Research |
